{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:57:25Z","timestamp":1769443045681,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s12272-011-0902-9","type":"journal-article","created":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T06:36:31Z","timestamp":1317796591000},"page":"1417-1426","source":"Crossref","is-referenced-by-count":19,"title":["Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker"],"prefix":"10.1007","volume":"34","author":[{"given":"Maryam","family":"Iman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asghar","family":"Davood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Reza","family":"Nematollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Rerza","family":"Dehpoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Shafiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,6]]},"reference":[{"key":"902_CR1","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/jm00159a022","volume":"29","author":"J. E. Arrowsmith","year":"1986","unstructured":"Arrowsmith, J. E., Campbell, S. F., Cross, P. E., Stubbs, J. K., Burges, R. A., Gardiner, D. G., and Blackburn, K. J., Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents. J. Med. Chem., 29, 1696\u20131702 (1986).","journal-title":"J. Med. Chem."},{"key":"902_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(25)33587-1","volume":"225","author":"G. T. Bolger","year":"1983","unstructured":"Bolger, G. T., Gengo, P., Klockowski, R., Luchowski, E., Siegel, H., Janis, R. A., Triggle, A. M., and Triggle, D. J., Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. J. Pharmacol. Exp. Ther., 225, 291\u2013309 (1983).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"902_CR3","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1021\/jm00119a009","volume":"31","author":"R. A. Coburn","year":"1988","unstructured":"Coburn, R. A., Wierzba, M., Suto, M. J., Solo, A. J., Triggle, A. M., and Triggle, D. J., 1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structureactivity relationship approach. J. Med. Chem., 31, 2103\u20132107 (1988).","journal-title":"J. Med. Chem."},{"key":"902_CR4","first-page":"381","volume":"140","author":"A. Davood","year":"2001","unstructured":"Davood, A., Khodarahmi, G., Alipour, E., Dehpour, K., Amini, M., and Shafiee, A., Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent. Boll. Chim. Farm., 140, 381\u2013386 (2001).","journal-title":"Boll. Chim. Farm."},{"key":"902_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ardp.200600013","volume":"339","author":"A. Davood","year":"2006","unstructured":"Davood, A., Mansouri, N., Rerza Dehpour, A., Shafaroudi, H., Alipour, E., and Shafiee, A., Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent. Arch. Pharm (Weinheim)., 339, 299\u2013304 (2006).","journal-title":"Arch. Pharm (Weinheim)."},{"key":"902_CR6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12272-009-1401-0","volume":"32","author":"A. Davood","year":"2009","unstructured":"Davood, A., Nematollahi, A. R., Iman, M., and Shafiee, A., Synthesis and docking studies of new 1,4-dihydropyridines containing 4-(5)-Chloro-2-ethyl-5-(4)-imidazolyl substituent as novel calcium channel agonist. Arch. Pharm. Res., 32, 481\u2013487 (2009).","journal-title":"Arch. Pharm. Res."},{"key":"902_CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00044-009-9171-2","volume":"19","author":"A. Davood","year":"2010","unstructured":"Davood, A., Nematollahi, A., Iman, M., and Shafiee, A., Computational studies of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent: QSAR and docking. Med. Chem. Res., 19, 58\u201370 (2010).","journal-title":"Med. Chem. Res."},{"key":"902_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pa.17.040177.001053","volume":"17","author":"A. Fleckenstein","year":"1977","unstructured":"Fleckenstein, A., Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol., 17, 149\u2013166 (1977).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"902_CR9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jps.2600830809","volume":"83","author":"A. C. Gaudio","year":"1994","unstructured":"Gaudio, A. C., Korolkovas, A., and Takahata, Y., Quantitative structure-activity relationships for 1,4-dihydropyridine calcium channel antagonists (nifedipine analogues): a quantum chemical\/classical approach. J. Pharm. Sci., 83, 1110\u20131115 (1994).","journal-title":"J. Pharm. Sci."},{"issue":"Suppl2","key":"902_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0773.1986.tb02518.x","volume":"58","author":"T. Godfraind","year":"1986","unstructured":"Godfraind, T., Calcium entry blockade and excitation contraction coupling in the cardiovascular system (with an attempt of pharmacological classification). Acta Pharmacol. Toxicol (Copenh)., 58Suppl 2, 5\u201330 (1986).","journal-title":"Acta Pharmacol. Toxicol (Copenh)."},{"key":"902_CR11","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/anie.199115591","volume":"30","author":"S. Goldmann","year":"1991","unstructured":"Goldmann, S. and Stoltefuss, J., 1,4-Dihydropyridines: effects of chirality and conformation on the calcium antagonist and calcium agonist activities. Angew. Chem. Int. Ed. Engl., 30, 1559\u20131578 (1991).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"902_CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/ar50020a002","volume":"2","author":"C. Hansch","year":"1969","unstructured":"Hansch, C., A quantitative approach to biochemical structure-activity relation-ships. Acc. Chem. Res., 2, 232\u2013239 (1969).","journal-title":"Acc. Chem. Res."},{"key":"902_CR13","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1021\/ja01062a035","volume":"86","author":"C. Hansch","year":"1964","unstructured":"Hansch, C. and Fujita, T., A method for the correlation of biological activity and chemical structure. J. Am. Chem. Soc., 86, 1616\u20131626 (1964).","journal-title":"J. Am. Chem. Soc."},{"key":"902_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlac.18822150102","volume":"215","author":"A. Hantzsch","year":"1882","unstructured":"Hantzsch, A., Ueber die Synthese Pyridinartiger Verbindungen aus Acetessigather und Aldehydammoniak. Justus Liebigs Ann. Chem., 215, 1\u201382 (1882).","journal-title":"Justus Liebigs Ann. Chem."},{"key":"902_CR15","unstructured":"Huey, R. and Morris, G. M., Using AutoDock 4 with Auto-DockTools, (2007)."},{"key":"902_CR16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/jm00360a001","volume":"26","author":"R. A. Janis","year":"1983","unstructured":"Janis, R. A. and Triggle, D. J., New developments in Ca2+ channel antagonists. J. Med. Chem., 26, 775\u2013785 (1983).","journal-title":"J. Med. Chem."},{"key":"902_CR17","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/jm980093j","volume":"41","author":"A. H. Li","year":"1998","unstructured":"Li, A. H., Moro, S., Melman, N., Ji, X. D., and Jacobson, K. A., Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J. Med. Chem., 41, 3186\u20133201 (1998).","journal-title":"J. Med. Chem."},{"key":"902_CR18","first-page":"165","volume":"3","author":"F. Pourmorad","year":"1997","unstructured":"Pourmorad, F., Hadizadeh, F., and Shafiee, A., Synthesis and calcium channel activity of 4-imidazolyl-1,4-dihydropyridines. Pharm. Sci., 3, 165\u2013168 (1997).","journal-title":"Pharm. Sci."},{"key":"902_CR19","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1021\/jm00095a023","volume":"35","author":"G. C. Rovnyak","year":"1992","unstructured":"Rovnyak, G. C., Atwal, K. S., Hedberg, A., Kimball, S. D., Moreland, S., Gougoutas, J. Z., O\u2019Reilly, B. C., Schwartz, J., and Malley, M. F., Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents. J. Med. Chem., 35, 3254\u20133263 (1992).","journal-title":"J. Med. Chem."},{"key":"902_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/303535a0","volume":"303","author":"M. Schramm","year":"1983","unstructured":"Schramm, M., Thomas, G., Towart, R., and Franckowiak, G., Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature, 303, 535\u2013537 (1983).","journal-title":"Nature"},{"key":"902_CR21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0031-6865(98)00004-1","volume":"73","author":"A. Shafiee","year":"1998","unstructured":"Shafiee, A., Dehpour, A. R., Hadizadeh, F., and Azimi, M., Syntheses and calcium channel antagonist activity of nifedipine analogues with methylsulfonylimidazolyl substituent. Pharm. Acta Helv., 73, 75\u201379 (1998).","journal-title":"Pharm. Acta Helv."},{"key":"902_CR22","first-page":"537","volume":"52","author":"A. Shafiee","year":"2002","unstructured":"Shafiee, A., Rastkary, N., and Jorjani, M., Synthesis and calcium channel antagonist activity of 1,4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents. Arzneimittelforschung, 52, 537\u2013542 (2002).","journal-title":"Arzneimittelforschung"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-011-0902-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-011-0902-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-011-0902-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T13:02:33Z","timestamp":1741784553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-011-0902-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["902"],"URL":"https:\/\/doi.org\/10.1007\/s12272-011-0902-9","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}